Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BIOMARIN PHARMACEUTICAL INC.”

112 pharma patents match "BIOMARIN PHARMACEUTICAL INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 112
Index total 30,257
Page 4 / 5

Quick answer

This filtered view shows 112 pharmaceutical patents matching "BIOMARIN PHARMACEUTICAL INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

112 results for “BIOMARIN PHARMACEUTICAL INC.” · 30,257 patents in full index Clear search

  1. US 8785168

    Formulations for lysosomal enzymes

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  2. US 8765437

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  3. US 8765945

    Processes of synthesizing dihydropyridophthalazinone derivatives

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  4. US 8735392

    Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt

    BIOMARIN PHARMACEUTICAL INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  5. US 8598121

    Variants of C-type natriuretic peptide

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  6. US 8563691

    Lysosomal targeting peptides and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  7. US 8541403

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  8. US 8492338

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted
  9. US 8492337

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted
  10. US 8420650

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  11. US 8420368

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  12. US 8377884

    Variants of C-type natriuretic peptides

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  13. US 8324210

    Pterin analogs

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  14. US 8207114

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  15. US 8198242

    Variants of C-type natriuretic peptide

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  16. US 8128925

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  17. US 8088760

    Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  18. US 8067416

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  19. US 8012976

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  20. US 8003126

    Stable tablet formulation

    BIOMARIN PHARMACEUTICAL INC. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted
  21. US 7981864

    Methods and compositions for targeting proteins across the blood brain barrier

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted
  22. US 7947681

    Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

    BIOMARIN PHARMACEUTICAL INC. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  23. US 7790433

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted
  24. US 7732599

    Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted